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Abstract
Background: Major depressive disorder (MDD) is a complex disease and a significant health problem that is prevalent across the world. Angiotensin-converting 
enzyme (ACE) has an important role in renin-angiotensin system (RAS) and converts inactive angiotensin I to a potent vasopressor and aldosterone-stimu-
lating peptide angiotensin II. Levels of ACE in plasma vary according to the insertion/deletion (I/D) polymorphism of ACE gene. Objective: The aim of the 
current study was to examine the influence ACE gene I/D variations on the risk of MDD. Methods: In the present case-control study, we analyzed ACE I/D 
polymorphism in 346 MDD patients and 210 healthy subjects using polymerase chain reaction technique. Results: Comparing the two groups, no significant 
difference was observed with regard to either genotype distributions or allele frequencies of the I/D polymorphism of ACE gene. Discussion: Our findings 
suggest that the ACE I/D polymorphism is not associated with MDD in Turkish case-control study. Further studies are still needed.
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Introduction
Major depressive disorder (MDD) is a common psychiatric disease, 
often associated with morbidity and mortality. Although many factors 
were considered as the cause of this disease, its etiology has not been 
ascertained yet. Studies with families, twins and fosterlings reveal that 
genetic factors play an important role in its etiology1. The prevalence 
of disease varies according to countries and age groups2. Studies sug-
gest that 10% to 15% of the general population will be exposed to 
clinical depression during their life1. Although the etiopathogenesis 
of the disease is not fully understood yet, it has been estimated that 
a genetic susceptibility could be effective in the onset of MDD3. 
Also, MDD is because of a complex genetic heterogeneity. Recent 
studies have shown that different genetic variants may contribute to 
the development of the MDD such as ACE gene polymorphism4-7. 
ACE gene, localized on chromosome 17q23, undergoes a poly-
morphism deriving from the presence (insertion, I) or absence 
(deletion, D) within intron 16, of a 287 base pair ALU repeat se-
quence8. Although each allele are codominant effect to ACE levels, 
the homozygosity for I and D alleles have the lowest and highest 
levels of the enzyme, respectively. Additionally, the heterozygosity 
have no effect to serum ACE levels5,9. ACE is also member of the 
renin-angiotensin system and acts a part in the conversion of an-
giotensin I to angiotensin II5. Angiotensin II is a peptide hormone 
which acts as a stimulator of proinflammatory cytokines and inter-
feres with hypothalamic-pituitary-adrenal (HPA) axis activation 
in response to stress5,10. It is mentioned from the effect of the brain 
renin-angiotensin system in regulation of mood11. It has been stated 
that ACE I/D polymorphism may be associated with suicide and 
MDD5. ACE is responsible for degeneration of neurokinins that play 
an important role in regulation of emotions. Angiotensin II is both a 
potent neuropeptide and have essential roles in cognitive processes12. 
In some studies, it has been shown that ACE may contribute to the 
pathophysiology of psychiatric diseases by interacting with central 
dopamine7. Therefore, it is important the investigation of ACE gene 
polymorphisms which are affecting an active to mood and personal 
stress. This case control study was designed to determine whether the 
ACE I/D gene polymorphism is related with susceptibility to MDD 
in Turkish population or not.
Material and methods
Subjects
In our study, 346 patients diagnosed with MDD (74 male and 272 
female) and 210 healthy volunteers (75 male and 134 females as con-
trol group) who were recruited to Tokat Gaziosmanpasa University, 
Department of Psychiatry were included to the study. According to 
Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) 
criteria, the patient group comprises individuals diagnosed with 
major depression. Both the study group and control group were 
recruited from the Turkish population. Subjects included to the 
study were greater than 18 years old. Informed written consent was 
obtained from all patients and subjects before enrollment to the 
study, according to the ethical guidelines of the 2008 Declaration of 
Helsinki and the investigation was approved by the ethical, inves-
tigation and biosecurity committee of Gaziosmanpasa University 
Faculty of Medicine. 
Genotype determination
This study was conducted in Gaziosmanpasa University, Department 
of Medical Biology and Genetics laboratories. Blood samples were 
collected from patients and controls. Genomic DNA was isolated 
from whole venous blood samples using a commercial DNA isolation 
kit (Sigma-Aldrich, Germany). In addition, after isolated, the DNA 
should be stored at -20C. ACE gene I/D polymorphism genotypes 
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were determined by polymerase chain reaction (PCR) using the prim-
ers and conditions described earlier8,11. Reactions were performed 
with 10 pmol of each primer: sense oligo, 5’-CTG GAG ACC ACT 
CCC ATC CTT TCT-3’, and antisense oligo, 5’-GAT GTG GCC ATC 
ACA TTC GTC AAG T-3’. Amplification was performed in a thermal 
cycler for 30 cycles with denaturation at 94ºC for 40 s, annealing at 
56ºC for 40 s and extension at 72ºC for 40 s, followed by a final exten-
sion at 72ºC for 10 min. PCR products were analyzed on 2% agarose 
gels after staining with ethidium bromide and were visualized using 
a UV transilluminator. The polymorphisms detected by PCR were 
evident as an approximately 490-bp fragment in the presence of the 
insertion (I) allele and as an approximately 190-bp fragment in the 
absence of insertion (D) allele. In heterozygous samples, two bands 
(490 and 190 bp) were detected. In order to confirm the accuracy and 
reproducibility of this method, each PCR reaction included internal 
controls for each genotype. Second PCR was performed to confirm 
samples whose results were not clear. 
Statistical analysis
All statistical analyses of data were performed using the computer 
software SPSS version 15.0 for Windows and OpenEpi Info software 
package program. Genotype distribution of the ACE gene and al-
lele frequency between MDD patients and controls were compared 
by Chi-Square test. Odds ratio (OR) and 95% confidence intervals 
(CIs) were calculated. Hardy-Weinberg equation was applied to the 
genotypes of the patients and controls. P values 0.05 or less were 
considered statistically significant. 
Results
Demographic variables and baseline characteristics of patients were 
presented in Table 1. The mean age ± standard deviation (SD) was 
38.12 ± 12.74 years in patients and 36.47 ± 9.33 years in control group. 
There were 74 (21.4%) males, 272 (78.6%) females and 75 (35.7%) 
males, 134 (63.8%) females in patient and control groups, respectively. 
The observed and expected frequencies of the polymorphism in both 
patient and control group were in Hardy-Weinberg equilibrium. It 
is determined that there was no statistical significant difference in 
the allele and genotype frequencies of ACE I/D polymorphism in 
patients and control groups (p > 0.05, OR 1.18, 95 % CI 0.91-1.51) 
(Table 2). Agarose gel electrophoresis patterns of ACE gene I/D 
polymorphisms were represented in Figure 1.
Discussion
In this study we assessed the association of ACE I/D polymorphism 
in patients with MDD. When we consider prevalence and etiologies 
of MDD, we think that the genetic background of MDD should be 
investigated. In this study, it was not found any association between 
patient and control groups in Turkish MDD population in terms of 
ACE I/D polymorphism. ACE, membrane-bound endopeptidase, is 
expressed in many tissues including brain13. It is reported that ACE in 
neuroepithelial cells degrades neurotransmitters such as substance P, 
which has a role in depression14 and that angiotensin II interacts with 
dopamine in some specific parts of brain15. Angiotensin II, acting as 
a stimulator of proinflammatory cytokines, makes changes on the 
hypothalamic-pituitary-adrenal (HPA) axis activation that develops 
in response to stress. ACE gene variations play a significant role in 
the HPA axis hyperactivity in depression. It has shown that varia-
tions in the ACE gene have an important impact on the HPA axis 
hyperactivity found in depression16. Captopril, an ACE inhibitor, is 
proved to have an antidepressant effect17. The fact that ACE gene 
variations affect serum enzyme level causes functional changes. ACE 
I/D polymorphism has been the subject of association studies related 
to various physiopathological conditions including mood disorder. 
It was reported that the depressive symptoms in schizophrenics was 
clearly associated with ACE I allele in the Chinese population7 and 
that D allele had a protective effect for schizophrenia in the Spanish 
population18. The researchers were also interested in whether ACE 
gene polymorphism affected the responses to therapeutic agents. 
It was reported that high activity of ACE genotype was associated 
with unfavorable response to conventional therapy in schizophrenic 
patients19. Kucukali et al. indicated that there was an association be-
tween D/D genotype and bipolar disorder in patients order and their 
first-degree relatives20. On the other hand, data collected previously 
suggested that ACE I/D polymorphism could possibly be a biological 
marker of depression21-24. On the basis of these findings, the studies 
related to the genetic background of the MDD patients will make 
an important contribution to the clarification of the relationship 
between ACE gene and MDD.
A meta-analysis evaluating the data of several studies indicated 
that there was no association between schizophrenia and ACE I/D 
Table 1. Clinical and demographic characteristics of the patients with MDD 
and healthy controls
Characteristics Control group, 
n (%)
Study group, 
n (%)
Gender, male/female 75/134 (35.7/63.8) 74/272 (21.4/78.6)
Age, mean ± SD, years 36.47 ± 9.33 38.12 ± 12,74
Weight, mean ± SD, years 70.97 ± 10.54
BMI, mean ± SD, years 26.51 ± 3.78
Age of onset 33.81 ± 12.25
Disease duration 4.75 ± 5.12
Civil status
Single/Married 73/165 (30.7/69.3)
Background of psychological disorders
No/Yes 148/90 (62.2/37.8)
Family history
No/Yes 150/88 (63.0/37.0)
Depression score 19.22 ± 11.22
Anxiety score 22.07 ± 14.48
Pain score 19.62 ± 11.30
BMI: body mass index.
Table 2. Genotype and allele frequencies of ACE gene polymorphisms in 
MDD patient and control groups
Gene MDD patients
n = 346
Healthy controls
n = 210 p    OR (CI 95%)
ACE (I/D)
Genotypes
I/I 
I/D
D/D
II: ID+DD
II+ID:DD
Alleles
I
D
44 (12.7%)
163 (47.1%)
139 (40.1%)
44:302
207:139
251 (36.2%)
441 (63.7%)
34 (16.19%)
101 (48.09%)
75 (35.71%)
34:176
135:75
169 (40.23%)
251 (59.76%)
0.40
> 0.05
> 0.05
0.18
0.75 (0.46-1.23)
0.77 (0.53-1.10)
1.18 (0.91-1.51)
Figure 1. Agarose gel electrophoresis patterns for I/D genotypes and genetic 
variations of ACE gene.
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polymorphism25, and the same result was supported in a study with 
the Croatian population26, in consistent with our study results. While 
it was reported that bipolar disorder was not associated with I/D poly-
morphism27, another study suggested that it was associated with I/D 
genotype in the Asian race28. ACE gene polymorphism was reported 
not to be related to panic disorder29,30, although the frequency of I 
allele is higher in men than women31. Another study stated that there 
was an association between ACE gene polymorphism and MDD 
only in female patients32, as consistent to our results. Arinami et al. 
found that D/D genotype increased sensitivity to affective disorder33. 
However, mood disorders that started in childhood were reported 
not to be associated with ACE polymorphism34. Studies conducted 
to examine the association between MDD and ACE did not show 
any link with ACE I/D polymorphism14,35-39. The same result was sup-
ported in Chinese population where it was reported that ACE gene 
polymorphism did not affect response to the treatment13. Also, Zill et 
al. suggest that aberrations in ACE promoter DNA methylation may 
be an underlying cause of MD40. Depression were also significantly 
associated with an increase in cortisol secretion and, it is stated that 
ACE gene rs4295, rs4311, rs4343, rs4291, rs4333 and rs4351 variati-
ons influence cortisol secretion41. ACE gene A2350G polymorphism 
was closely associated with MDD among Iranian population12. 
Stewart et al. reported that there was no difference between MDD 
and control groups with regard to allele and genotype42. Considering 
this informations, we think that ACE I/D polymorphism was not 
related to the development of MDD in Turkish patients. Because the 
number of studies performed on the association of the ACE gene with 
Turkish MDD is limited, we think that the present study provides an 
important contribution to the literature.
Conclusions
In the present study, we not found a significant association between 
the ACE gene I/D polymorphism and MDD in Turkish population. 
The results cannot explain the role of ACE I/D polymorphism in 
the development of MDD. This polymorphism is not a susceptibil-
ity factor to MDD in the Turkish population. Although the present 
study does not provide any difference between the groups, we believe 
that there is a need for more comprehensive studies in different 
populations. 
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